(ISSN 2577-5804)
Welcome to the new academic journal OBM Hepatology and Gastroenterology. Recent progress in understanding liver, biliary, pancreatic and gastro-intestinal diseases and their treatments has been observed in the world. OBM Hepatology and Gastroenterology publishes interesting and informative reviews, original articles, and invaluable case reports in this area. We also publish basic research as well as clinical research.
Hepatitis A virus (HAV), HBV, HCV, HDV, and HEV are still a serious issue worldwide. Treatments on these viruses have recently improved. However, liver fibrosis, cirrhosis and hepatocellular carcinoma are still critical conditions. We focus on all of these liver diseases. We also focus on broad-spectrum of gastro-intestinal diseases in this journal.
Please accept our special thanks for choosing to publish in the OBM Hepatology and Gastroenterology. We are looking forward to your submissions for OBM Hepatology and Gastroenterology.
Indexing: DOAJ-Directory of Open Access Journals.
Archiving: full-text archived in CLOCKSS.
Special Issue
Gut Microbiota and Gut Health
Submission Deadline: December 31, 2020 (Open) Submit Now
Guest Editor
Rostyslav Bubnov, MD, PhD, LLM
Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kyiv, Ukraine
Research Interests: Microbiome, Metabolic syndrome, Gut health, Probiotics, Prebiotics, Predictive preventive personalized medicine, Radiology, Ultrasound, Lactobacillus, Bifidobacterium
About this Topic
Gut microbiota (GM) has close interaction with human metabolism and immune system. Gut and distant sites microbiome, directly or indirect mechanisms of impact on gut and metabolic health via interaction with intestinal mucosa and producing metabolites. The issue "Gut Microbiota and Gut Health" covers the novel aspects of gut health associated with microbiome, includes contributions on innovative hypotheses, basic research and clinical trials capable to increase the up to date evidence. Studies of complexity of microbial composition and diversity as a potential diagnostic and predictive biomarker and potential targeted treatments based on modulating mirobiome, namely using probiotics, prebiotics, fecal microbiota transplantation (FMT), dietary interventions and novel treatment approaches which need personalization.
- Newsletter